The subtype defined as triple negative breast cancer (TNBC) is negative for estrogen receptor, progesterone receptor, and the human epidermal growth factor receptor 2 (Her2).[2] TNBC accounts for 10-15% of all breast cancer cases and has a higher rate of mortality than other malignancies. This evidence concerns the gene ERBB2 and breast carcinoma.